Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Minerva Neurosciences (NERV) has provided an update.
Jeryl Hilleman will step down from her position on the Board and Chair of the Audit Committee at Minerva Neurosciences, effective August 6, 2024, to pursue other opportunities, with no disagreements prompting her departure. Jan van Heek will assume the role of Chair, and Dr. David Kupfer will join the Audit Committee following Hilleman’s resignation.
See more data about NERV stock on TipRanks’ Stock Analysis page.